{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:21:15Z","timestamp":1784733675048,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":185,"publisher":"Springer US","isbn-type":[{"value":"9781071642894","type":"print"},{"value":"9781071642900","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4290-0_4","type":"book-chapter","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T19:30:12Z","timestamp":1734636612000},"page":"79-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Non-coding RNAs in Tumorigenesis, Diagnosis\/Prognosis, and Therapeutic Strategies for Cutaneous Melanoma"],"prefix":"10.1007","author":[{"given":"Niels","family":"Schaft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"D\u00f6rrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154232","volume":"241","author":"F Dashti","year":"2023","unstructured":"Dashti F, Mirazimi SMA, Kazemioula G, Mohammadi M, Hosseini M, Razaghi Bahabadi Z, Mirazimi MS, Abadi M, Shahini A, Afshari M, Mirzaei H (2023) Long non-coding RNAs and melanoma: from diagnosis to therapy. Pathol Res Pract 241:154232. https:\/\/doi.org\/10.1016\/j.prp.2022.154232","journal-title":"Pathol Res Pract"},{"key":"4_CR2","doi-asserted-by":"publisher","unstructured":"Melixetian M, Pelicci PG, Lanfrancone L (2022) Regulation of LncRNAs in melanoma and their functional roles in the metastatic process. Cells 11(3). https:\/\/doi.org\/10.3390\/cells11030577","DOI":"10.3390\/cells11030577"},{"key":"4_CR3","doi-asserted-by":"publisher","unstructured":"Wozniak M, Czyz M (2021) The functional role of long non-coding RNAs in melanoma. Cancers (Basel) 13(19). https:\/\/doi.org\/10.3390\/cancers13194848","DOI":"10.3390\/cancers13194848"},{"issue":"1","key":"4_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.26355\/eurrev_202301_30853","volume":"27","author":"SX Zi","year":"2023","unstructured":"Zi SX, Xing YM, Wang CZ (2023) mRNA and long-noncoding RNA signatures for improving the prognosis prediction of cutaneous skin melanoma efficiently. Eur Rev Med Pharmacol Sci 27(1):66\u201373. https:\/\/doi.org\/10.26355\/eurrev_202301_30853","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"4_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18109","volume":"28","author":"M Masrour","year":"2024","unstructured":"Masrour M, Khanmohammadi S, Fallahtafti P, Hashemi SM, Rezaei N (2024) Long non-coding RNA as a potential diagnostic and prognostic biomarker in melanoma: a systematic review and meta-analysis. J Cell Mol Med 28(3):e18109. https:\/\/doi.org\/10.1111\/jcmm.18109","journal-title":"J Cell Mol Med"},{"issue":"5","key":"4_CR6","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.18632\/aging.205606","volume":"16","author":"Q Wan","year":"2024","unstructured":"Wan Q, Deng Y, Wei R, Ma K, Tang J, Deng YP (2024) Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy. Aging (Albany NY) 16(5):4518\u20134540. https:\/\/doi.org\/10.18632\/aging.205606","journal-title":"Aging (Albany NY)"},{"key":"4_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.985051","volume":"13","author":"S Guo","year":"2022","unstructured":"Guo S, Chen J, Yi X, Lu Z, Guo W (2022) Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma. Front Immunol 13:985051. https:\/\/doi.org\/10.3389\/fimmu.2022.985051","journal-title":"Front Immunol"},{"issue":"2","key":"4_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10142-023-01029-9","volume":"23","author":"W Li","year":"2023","unstructured":"Li W, Zhan Y, Peng C, Wang Z, Xu T, Liu M (2023) A model based on immune-related lncRNA pairs and its potential prognostic value in immunotherapy for melanoma. Funct Integr Genomics 23(2):91. https:\/\/doi.org\/10.1007\/s10142-023-01029-9","journal-title":"Funct Integr Genomics"},{"issue":"1","key":"4_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.slast.2023.08.001","volume":"29","author":"W Lin","year":"2024","unstructured":"Lin W, Tan ZY, Fang XC (2024) Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma. SLAS Technol 29(1):100101. https:\/\/doi.org\/10.1016\/j.slast.2023.08.001","journal-title":"SLAS Technol"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"1180732","DOI":"10.3389\/fendo.2023.1180732","volume":"14","author":"Z Cui","year":"2023","unstructured":"Cui Z, Liang Z, Song B, Zhu Y, Chen G, Gu Y, Liang B, Ma J, Song B (2023) Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization. Front Endocrinol (Lausanne) 14:1180732. https:\/\/doi.org\/10.3389\/fendo.2023.1180732","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4_CR11","doi-asserted-by":"publisher","first-page":"7299","DOI":"10.1038\/s41598-023-34238-0","volume":"13","author":"M Zhang","year":"2023","unstructured":"Zhang M, Yang L, Wang Y, Zuo Y, Chen D, Guo X (2023) Comprehensive prediction of immune microenvironment and hot and cold tumor differentiation in cutaneous melanoma based on necroptosis-related lncRNA. Sci Rep 13(1):7299. https:\/\/doi.org\/10.1038\/s41598-023-34238-0","journal-title":"Sci Rep"},{"issue":"1","key":"4_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1186\/s12885-023-11246-x","volume":"23","author":"J Liu","year":"2023","unstructured":"Liu J, Luo B, Zhang P, Jiang K, Hou Z, Cao X, Tang J (2023) Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy. BMC Cancer 23(1):752. https:\/\/doi.org\/10.1186\/s12885-023-11246-x","journal-title":"BMC Cancer"},{"issue":"4","key":"4_CR13","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.62347\/lhkw3124","volume":"14","author":"Y Wu","year":"2024","unstructured":"Wu Y, Yin S, Li C, Zhao L, Song M, Yu Y, Tang L, Yang Y (2024) A signature of seven hypoxia-related lncRNAs is a potential biomarker for predicting the prognosis of melanoma. Am J Cancer Res 14(4):1712\u20131729. https:\/\/doi.org\/10.62347\/lhkw3124","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4_CR14","doi-asserted-by":"publisher","first-page":"16332","DOI":"10.1038\/s41598-023-39837-5","volume":"13","author":"M Zhang","year":"2023","unstructured":"Zhang M, Zuo Y, Guo J, Yang L, Wang Y, Tan M, Guo X (2023) A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs. Sci Rep 13(1):16332. https:\/\/doi.org\/10.1038\/s41598-023-39837-5","journal-title":"Sci Rep"},{"issue":"15","key":"4_CR15","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.18632\/aging.204932","volume":"15","author":"L Zhong","year":"2023","unstructured":"Zhong L, Qian W, Gong W, Zhu L, Zhu J (2023) Development of anoikis-related long non-coding RNA signature associated with prognosis and immune landscape in cutaneous melanoma patients. Aging (Albany NY) 15(15):7655\u20137672. https:\/\/doi.org\/10.18632\/aging.204932","journal-title":"Aging (Albany NY)"},{"key":"4_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.643613","volume":"11","author":"K Wu","year":"2021","unstructured":"Wu K, Wang Q, Liu YL, Xiang Z, Wang QQ, Yin L, Liu SL (2021) LncRNA POU3F3 contributes to Dacarbazine resistance of human melanoma through the MiR-650\/MGMT Axis. Front Oncol 11:643613. https:\/\/doi.org\/10.3389\/fonc.2021.643613","journal-title":"Front Oncol"},{"issue":"3","key":"4_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00432-020-03484-4","volume":"147","author":"Y Han","year":"2021","unstructured":"Han Y, Fang J, Xiao Z, Deng J, Zhang M, Gu L (2021) Downregulation of lncRNA TSLNC8 promotes melanoma resistance to BRAF inhibitor PLX4720 through binding with PP1\u03b1 to re-activate MAPK signaling. J Cancer Res Clin Oncol 147(3):767\u2013777. https:\/\/doi.org\/10.1007\/s00432-020-03484-4","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"4_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/cmr.0000000000000560","volume":"29","author":"B Pan","year":"2019","unstructured":"Pan B, Lin X, Zhang L, Hong W, Zhang Y (2019) Long noncoding RNA X-inactive specific transcript promotes malignant melanoma progression and oxaliplatin resistance. Melanoma Res 29(3):254\u2013262. https:\/\/doi.org\/10.1097\/cmr.0000000000000560","journal-title":"Melanoma Res"},{"key":"4_CR019","doi-asserted-by":"publisher","unstructured":"Binder AK, Bremm F, D\u00f6rrie J (2024) Non-coding RNA in tumor cells and tumor-associated myeloid cells-function and therapeutic potential. Schaft N Int J Mol Sci 25(13):7275. https:\/\/doi.org\/10.3390\/ijms25137275","DOI":"10.3390\/ijms25137275"},{"issue":"1","key":"4_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41420-024-01922-7","volume":"10","author":"L Cong","year":"2024","unstructured":"Cong L, Zhao Q, Sun H, Zhou Z, Hu Y, Li C, Hao M, Cong X (2024) A novel long non-coding RNA SLNCR1 promotes proliferation, migration, and invasion of melanoma via transcriptionally regulating SOX5. Cell Death Discov 10(1):160. https:\/\/doi.org\/10.1038\/s41420-024-01922-7","journal-title":"Cell Death Discov"},{"issue":"1","key":"4_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-024-01955-7","volume":"23","author":"V Feichtenschlager","year":"2024","unstructured":"Feichtenschlager V, Chen L, Zheng YJ, Ho W, Sanlorenzo M, Vujic I, Fewings E, Lee A, Chen C, Callanan C, Lin K, Qu T, Hohlova D, Vujic M, Hwang Y, Lai K, Chen S, Nguyen T, Mu\u00f1oz DP, Kohwi Y, Posch C, Daud A, Rappersberger K, Kohwi-Shigematsu T, Copp\u00e9 JP, Ortiz-Urda S (2024) The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS\/MAPK-driven melanoma. Mol Cancer 23(1):40. https:\/\/doi.org\/10.1186\/s12943-024-01955-7","journal-title":"Mol Cancer"},{"issue":"3","key":"4_CR21","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050852","volume":"22","author":"M Melixetian","year":"2021","unstructured":"Melixetian M, Bossi D, Mihailovich M, Punzi S, Barozzi I, Marocchi F, Cuomo A, Bonaldi T, Testa G, Marine JC, Leucci E, Minucci S, Pelicci PG, Lanfrancone L (2021) Long non-coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation. EMBO Rep 22(3):e50852. https:\/\/doi.org\/10.15252\/embr.202050852","journal-title":"EMBO Rep"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2147\/cmar.S281920","volume":"13","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhang J, Zhang Q, Xu H, Liu L (2021) Long non-coding RNA HOXA11-AS modulates proliferation, apoptosis, metastasis and EMT in cutaneous melanoma cells partly via miR-152-3p\/ITGA9 Axis. Cancer Manag Res 13:925\u2013939. https:\/\/doi.org\/10.2147\/cmar.S281920","journal-title":"Cancer Manag Res"},{"issue":"11","key":"4_CR23","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41419-020-03141-1","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang S, Wan H, Zhang X (2020) LncRNA LHFPL3-AS1 contributes to tumorigenesis of melanoma stem cells via the miR-181a-5p\/BCL2 pathway. Cell Death Dis 11(11):950. https:\/\/doi.org\/10.1038\/s41419-020-03141-1","journal-title":"Cell Death Dis"},{"issue":"11","key":"4_CR24","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1158\/1541-7786.Mcr-19-1046","volume":"18","author":"Q Peng","year":"2020","unstructured":"Peng Q, Liu L, Pei H, Zhang J, Chen M, Zhai X (2020) A LHFPL3-AS1\/miR-580-3p\/STAT3 feedback loop promotes the malignancy in melanoma via activation of JAK2\/STAT3 signaling. Mol Cancer Res 18(11):1724\u20131734. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-1046","journal-title":"Mol Cancer Res"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.12659\/msm.906616","volume":"24","author":"J Long","year":"2018","unstructured":"Long J, Menggen Q, Wuren Q, Shi Q, Pi X (2018) Long noncoding RNA Taurine-Upregulated Gene1 (TUG1) promotes tumor growth and metastasis through TUG1\/Mir-129-5p\/Astrocyte-Elevated Gene-1 (AEG-1) Axis in malignant melanoma. Med Sci Monit 24:1547\u20131559. https:\/\/doi.org\/10.12659\/msm.906616","journal-title":"Med Sci Monit"},{"issue":"2","key":"4_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5","journal-title":"Cell"},{"issue":"6","key":"4_CR27","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3892\/ijo.2017.4173","volume":"51","author":"B Cai","year":"2017","unstructured":"Cai B, Zheng Y, Ma S, Xing Q, Wang X, Yang B, Yin G, Guan F (2017) BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to upregulate Notch2 expression by sponging miR-204. Int J Oncol 51(6):1941\u20131951. https:\/\/doi.org\/10.3892\/ijo.2017.4173","journal-title":"Int J Oncol"},{"issue":"3","key":"4_CR28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3892\/ijmm.2017.3335","volume":"41","author":"L Chen","year":"2018","unstructured":"Chen L, Ma D, Li Y, Li X, Zhao L, Zhang J, Song Y (2018) Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma. Int J Mol Med 41(3):1275\u20131282. https:\/\/doi.org\/10.3892\/ijmm.2017.3335","journal-title":"Int J Mol Med"},{"issue":"6","key":"4_CR29","first-page":"1191","volume":"21","author":"YN Chen","year":"2017","unstructured":"Chen YN (2017) Dacarbazine inhibits proliferation of melanoma FEMX-1 cells by up-regulating expression of miRNA-200. Eur Rev Med Pharmacol Sci 21(6):1191\u20131197","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"49","key":"4_CR30","doi-asserted-by":"publisher","first-page":"85401","DOI":"10.18632\/oncotarget.19910","volume":"8","author":"W Luan","year":"2017","unstructured":"Luan W, Li R, Liu L, Ni X, Shi Y, Xia Y, Wang J, Lu F, Xu B (2017) Long non-coding RNA HOTAIR acts as a competing endogenous RNA to promote malignant melanoma progression by sponging miR-152-3p. Oncotarget 8(49):85401\u201385414. https:\/\/doi.org\/10.18632\/oncotarget.19910","journal-title":"Oncotarget"},{"issue":"9","key":"4_CR31","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/iub.2345","volume":"72","author":"SA Nabipoorashrafi","year":"2020","unstructured":"Nabipoorashrafi SA, Shomali N, Sadat-Hatamnezhad L, Mahami-Oskouei M, Mahmoudi J, Sandoghchian Shotorbani B, Akbari M, Xu H, Sandoghchian Shotorbani S (2020) miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro. IUBMB Life 72(9):2034\u20132044. https:\/\/doi.org\/10.1002\/iub.2345","journal-title":"IUBMB Life"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"1173035","DOI":"10.3389\/fimmu.2023.1173035","volume":"14","author":"PK Vaddi","year":"2023","unstructured":"Vaddi PK, Osborne DG, Nicklawsky A, Williams NK, Menon DR, Smith D, Mayer J, Reid A, Domenico J, Nguyen GH, Robinson WA, Ziman M, Gao D, Zhai Z, Fujita M (2023) CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients. Front Immunol 14:1173035. https:\/\/doi.org\/10.3389\/fimmu.2023.1173035","journal-title":"Front Immunol"},{"issue":"33","key":"4_CR33","doi-asserted-by":"publisher","first-page":"53558","DOI":"10.18632\/oncotarget.10669","volume":"7","author":"X Sun","year":"2016","unstructured":"Sun X, Li J, Sun Y, Zhang Y, Dong L, Shen C, Yang L, Yang M, Li Y, Shen G, Tu Y, Tao J (2016) miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR\/IGF-1R\/CRAF and inhibiting the MAPK and PI3K\/AKT signaling pathways. Oncotarget 7(33):53558\u201353570. https:\/\/doi.org\/10.18632\/oncotarget.10669","journal-title":"Oncotarget"},{"issue":"3","key":"4_CR34","first-page":"961","volume":"28","author":"N Liu","year":"2012","unstructured":"Liu N, Sun Q, Chen J, Li J, Zeng Y, Zhai S, Li P, Wang B, Wang X (2012) MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-\u03baB1 pathway. Oncol Rep 28(3):961\u2013968","journal-title":"Oncol Rep"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.genrep.2016.09.001","volume":"5","author":"MA Elkady","year":"2016","unstructured":"Elkady MA, Abd-Allah GM, Doghish AS, Yousef AA, Mohammad OI (2016) Matrix metalloproteinase (MMP)-2-1306 C> T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients. Gene Rep 5:57\u201361","journal-title":"Gene Rep"},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.gene.2019.05.043","volume":"710","author":"S Wang","year":"2019","unstructured":"Wang S, Wu Y, Xu Y, Tang X (2019) miR-10b promoted melanoma progression through Wnt\/\u03b2-catenin pathway by repressing ITCH expression. Gene 710:39\u201347","journal-title":"Gene"},{"issue":"3","key":"4_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.22074\/cellj.2021.7311","volume":"23","author":"P Sahranavardfard","year":"2021","unstructured":"Sahranavardfard P, Madjd Z, Emami Razavi AN, Ghanadan AR, Firouzi J, Khosravani P, Ghavami S, Ebrahimie E, Ebrahimi M (2021) An integrative analysis of the micro-RNAs contributing in Stemness, metastasis and B-Raf pathways in malignant melanoma and melanoma stem cell. Cell J 23(3):261\u2013272. https:\/\/doi.org\/10.22074\/cellj.2021.7311","journal-title":"Cell J"},{"issue":"1","key":"4_CR38","first-page":"1","volume":"23","author":"Y Guo","year":"2021","unstructured":"Guo Y, Shi W, Fang R (2021) miR-18a-5p promotes melanoma cell proliferation and inhibits apoptosis and autophagy by targeting EPHA7 signaling. Mol Med Rep 23(1):1\u20131","journal-title":"Mol Med Rep"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"433\u2013442","DOI":"10.1093\/jnci\/djt003","volume":"105(6)","author":"AA Dar","year":"2013","unstructured":"Dar AA, Majid S, Rittsteuer C, de Semir D, Bezrookove V, Tong S, Nosrati M, Sagebiel R, Miller JR III, Kashani-Sabet M (2013) The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst 105(6):433\u2013442. https:\/\/doi.org\/10.1093\/jnci\/djt003","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4_CR40","first-page":"791","volume":"53","author":"YP Wei","year":"2018","unstructured":"Wei YP, Wang XH, Liu G, Zhang JF, Yang YX, Zhang J, Song XL, Li ZD, Zhao LD (2018) Matrine exerts inhibitory effects in melanoma through the regulation of miR-19b-3p\/PTEN. Int J Oncol 53(2):791\u2013800","journal-title":"Int J Oncol"},{"issue":"28","key":"4_CR41","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/onc.2014.294","volume":"34","author":"H Mathsyaraja","year":"2015","unstructured":"Mathsyaraja H, Thies K, Taffany DA, Deighan C, Liu T, Yu L, Fernandez SA, Shapiro C, Otero J, Timmers C, Lustberg MB, Chalmers J, Leone G, Ostrowski MC (2015) CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth. Oncogene 34(28):3651\u20133661. https:\/\/doi.org\/10.1038\/onc.2014.294","journal-title":"Oncogene"},{"key":"4_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145552","volume":"782","author":"Y Hino","year":"2021","unstructured":"Hino Y, Rahman MM, Lai YC, Husna AA, Chen HW, Hasan MN, Nakagawa T, Miura N (2021) Hypoxic miRNAs expression are different between primary and metastatic melanoma cells. Gene 782:145552. https:\/\/doi.org\/10.1016\/j.gene.2021.145552","journal-title":"Gene"},{"issue":"3","key":"4_CR43","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/mc.22542","volume":"56","author":"XH Mao","year":"2017","unstructured":"Mao XH, Chen M, Wang Y, Cui PG, Liu SB, Xu ZY (2017) MicroRNA-21 regulates the ERK\/NF-\u03baB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN. Mol Carcinog 56(3):886\u2013894","journal-title":"Mol Carcinog"},{"issue":"12","key":"4_CR44","first-page":"5332","volume":"23","author":"L Shi","year":"2019","unstructured":"Shi L, Huo J-W, Chen S-S, Xue J-X, Gao W-Y, Li X-Y, Song Y-H, Xu H-T, Zhu X-W, Chen K (2019) MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt\/\u03b2-catenin signaling pathway and epithelial-mesenchymal transition. Eur Rev Med Pharm Sci 23(12):5332","journal-title":"Eur Rev Med Pharm Sci"},{"issue":"10","key":"4_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2217\/fon-2019-0699","volume":"16","author":"R Lv","year":"2020","unstructured":"Lv R, Yu J, Sun Q (2020) Anti-angiogenic role of microRNA-23b in melanoma by disturbing NF-\u03baB signaling pathway via targeted inhibition of NAMPT. Future Oncol 16(10):541\u2013458. https:\/\/doi.org\/10.2217\/fon-2019-0699","journal-title":"Future Oncol"},{"issue":"11","key":"4_CR46","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/ijms17111124","volume":"17","author":"J Huo","year":"2016","unstructured":"Huo J, Zhang Y, Li R, Wang Y, Wu J, Zhang D (2016) Upregulated microRNA-25 mediates the migration of melanoma cells by targeting DKK3 through the WNT\/\u03b2-catenin pathway. Int J Mol Sci 17(11):1124","journal-title":"Int J Mol Sci"},{"key":"4_CR47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1051\/medsci\/201834f111","volume":"34","author":"Q-Q Jiang","year":"2018","unstructured":"Jiang Q-Q, Liu W-B (2018) miR-25 promotes melanoma progression by regulating RNA binding motif protein 47. M\u00e9decine\/Sciences 34:59\u201365","journal-title":"M\u00e9decine\/Sciences"},{"issue":"5","key":"4_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.12631","volume":"21","author":"Y Tian","year":"2021","unstructured":"Tian Y, Zeng J, Yang Z (2021) MicroRNA-27b inhibits the development of melanoma by targeting MYC. Oncol Lett 21(5):1\u201310","journal-title":"Oncol Lett"},{"issue":"20","key":"4_CR49","first-page":"8991","volume":"23","author":"H Sun","year":"2019","unstructured":"Sun H, Yang G, Wang S, Zhang Y, Ding J, Zhang X (2019) MicroRNA-92a regulates the development of cutaneous malignant melanoma by mediating FOXP1. Eur Rev Med Pharm Sci 23(20):8991","journal-title":"Eur Rev Med Pharm Sci"},{"issue":"1","key":"4_CR50","first-page":"331","volume":"39","author":"X-\u0395 Chen","year":"2018","unstructured":"Chen X-\u0395, Chen P, Chen S-S, Ma T, Shi G, Zhou Y, Li J, Sheng L (2018) miR-106b-5p promotes cell cycle progression of malignant melanoma by targeting PTEN. Oncol Rep 39(1):331\u2013337","journal-title":"Oncol Rep"},{"issue":"6","key":"4_CR51","first-page":"6356","volume":"8","author":"J-W Ren","year":"2015","unstructured":"Ren J-W, Li Z-J, Tu C (2015) MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells. Int J Clin Exp Pathol 8(6):6356","journal-title":"Int J Clin Exp Pathol"},{"key":"4_CR52","doi-asserted-by":"crossref","first-page":"BSR20170743","DOI":"10.1042\/BSR20170743","volume":"37(5)","author":"J-J Wang","year":"2017","unstructured":"Wang J-J, Li Z-F, Li X-J, Han Z, Zhang L, Liu Z-J (2017) Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial\u2013mesenchymal transition by targetting PMEL through the Wnt signaling pathway. Biosci Rep 37(5):BSR20170743","journal-title":"Biosci Rep"},{"issue":"24","key":"4_CR53","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1080\/15384101.2019.1690881","volume":"18","author":"C Yang","year":"2019","unstructured":"Yang C, Xia Z, Zhu L, Li Y, Zheng Z, Liang J, Wu L (2019) MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K\/AKT signaling pathway by binding to IGF1R. Cell Cycle 18(24):3513\u20133524","journal-title":"Cell Cycle"},{"key":"4_CR54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.omto.2020.03.009","volume":"17","author":"Y He","year":"2020","unstructured":"He Y, Yang Y, Liao Y, Xu J, Liu L, Li C, Xiong X (2020) RETRACTED: miR-140-3p inhibits cutaneous melanoma progression by disrupting AKT\/p70S6K and JNK pathways through ABHD2. Mol Ther Oncolyt 17:83\u201393","journal-title":"Mol Ther Oncolyt"},{"key":"4_CR55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01460","volume":"3","author":"M Forloni","year":"2014","unstructured":"Forloni M, Dogra SK, Dong Y, Conte D Jr, Ou J, Zhu LJ, Deng A, Mahalingam M, Green MR, Wajapeyee N (2014) miR-146a promotes the initiation and progression of melanoma by activating Notch signaling. elife 3:e01460","journal-title":"elife"},{"issue":"1","key":"4_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00441-012-1514-5","volume":"351","author":"M Sand","year":"2013","unstructured":"Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG (2013) Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell Tissue Res 351(1):85\u201398. https:\/\/doi.org\/10.1007\/s00441-012-1514-5","journal-title":"Cell Tissue Res"},{"issue":"2","key":"4_CR57","first-page":"1475","volume":"15","author":"J Wan","year":"2018","unstructured":"Wan J, Yang J, Huang Y, Deng L (2018) MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4. Oncol Lett 15(2):1475\u20131482","journal-title":"Oncol Lett"},{"issue":"1","key":"4_CR58","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13046-018-0911-3","volume":"37","author":"X Zhou","year":"2018","unstructured":"Zhou X, Yan T, Huang C, Xu Z, Wang L, Jiang E, Wang H, Chen Y, Liu K, Shao Z, Shang Z (2018) Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1\/JAK2\/STAT3 signaling pathway. J Exp Clin Cancer Res 37(1):242. https:\/\/doi.org\/10.1186\/s13046-018-0911-3","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"4_CR59","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cell.2012.10.028","volume":"151","author":"N Pencheva","year":"2012","unstructured":"Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K, Tavazoie SF (2012) Convergent multi-miRNA targeting of ApoE drives LRP1\/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151(5):1068\u20131082. https:\/\/doi.org\/10.1016\/j.cell.2012.10.028","journal-title":"Cell"},{"issue":"1","key":"4_CR60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41420-022-00993-8","volume":"8","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Chen H, Li X, Zeng B, Sun Z, Liu D, Chen Y, Zhang Y, Rosie Xing H, Wang J (2022) Low-metastatic melanoma cells acquire enhanced metastatic capability via exosomal transfer of miR-199a-1-5p from highly metastatic melanoma cells. Cell Death Discov 8(1):188","journal-title":"Cell Death Discov"},{"issue":"22","key":"4_CR61","doi-asserted-by":"publisher","first-page":"22759","DOI":"10.18632\/aging.103909","volume":"12","author":"WJ Zhou","year":"2020","unstructured":"Zhou WJ, Wang HY, Zhang J, Dai HY, Yao ZX, Zheng Z, Meng-Yan S, Wu K (2020) NEAT1\/miR-200b-3p\/SMAD2 axis promotes progression of melanoma. Aging (Albany NY) 12(22):22759\u201322775. https:\/\/doi.org\/10.18632\/aging.103909","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"4_CR62","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jid.2017.09.049","volume":"138","author":"W Lohcharoenkal","year":"2018","unstructured":"Lohcharoenkal W, Das Mahapatra K, Pasquali L, Crudden C, Kular L, Akkaya Ulum YZ, Zhang L, Xu Land\u00e9n N, Girnita L, Jagodic M, St\u00e5hle M, Sonkoly E, Pivarcsi A (2018) Genome-wide screen for MicroRNAs reveals a role for miR-203 in melanoma metastasis. J Invest Dermatol 138(4):882\u2013892. https:\/\/doi.org\/10.1016\/j.jid.2017.09.049","journal-title":"J Invest Dermatol"},{"issue":"6","key":"4_CR63","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/mt.2013.70","volume":"21","author":"S Noguchi","year":"2013","unstructured":"Noguchi S, Iwasaki J, Kumazaki M, Mori T, Maruo K, Sakai H, Yamada N, Shimada K, Naoe T, Kitade Y, Akao Y (2013) Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo. Mol Ther 21(6):1204\u20131211. https:\/\/doi.org\/10.1038\/mt.2013.70","journal-title":"Mol Ther"},{"issue":"4","key":"4_CR64","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.18632\/aging.202450","volume":"13","author":"J Guo","year":"2021","unstructured":"Guo J, Gan Q, Gan C, Zhang X, Ma X, Dong M (2021) LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p\/VEGFA axis. Aging (Albany NY) 13(4):5297\u20135311. https:\/\/doi.org\/10.18632\/aging.202450","journal-title":"Aging (Albany NY)"},{"issue":"Pt A","key":"4_CR65","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biocel.2016.11.004","volume":"81","author":"H Maadi","year":"2016","unstructured":"Maadi H, Moshtaghian A, Taha MF, Mowla SJ, Kazeroonian A, Haass NK, Javeri A (2016) Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer. Int J Biochem Cell Biol 81(Pt A):121\u2013132. https:\/\/doi.org\/10.1016\/j.biocel.2016.11.004","journal-title":"Int J Biochem Cell Biol"},{"issue":"12","key":"4_CR66","doi-asserted-by":"crossref","first-page":"23518","DOI":"10.1002\/jcp.28920","volume":"234","author":"Y Mo","year":"2019","unstructured":"Mo Y, Fang RH, Wu J, Si Y, Jia SQ, Li Q, Bai JZ, She XN, Wang JQ (2019) MicroRNA-329 upregulation impairs the HMGB2\/\u03b2-catenin pathway and regulates cell biological behaviors in melanoma. J Cell Physiol 234(12):23518\u201323527","journal-title":"J Cell Physiol"},{"key":"4_CR67","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.abb.2014.07.012","volume":"563","author":"AMP Strong","year":"2014","unstructured":"Strong AMP, Setaluri V, Spiegelman VS (2014) microRNA-340 as a modulator of RAS\u2013RAF\u2013MAPK signaling in melanoma. Arch Biochem Biophys 563:118\u2013124","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"4_CR68","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3727\/096504018X15193823766141","volume":"26","author":"Q Shi","year":"2018","unstructured":"Shi Q, He Q, Wei J (2018) MicroRNA-342 prohibits proliferation and invasion of melanoma cells by directly targeting zinc-finger E-box-binding Homeobox 1. Oncol Res 26(9):1447","journal-title":"Oncol Res"},{"key":"4_CR69","first-page":"3679","volume":"24","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Wen X, Zhao P (2018) MicroRNA-365 inhibits cell growth and promotes apoptosis in melanoma by targeting BCL2 and cyclin D1 (CCND1). Med Sci Monit Int Med J Exp Clin Res 24:3679","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"issue":"2","key":"4_CR70","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41389-020-0203-6","volume":"9","author":"MG Tupone","year":"2020","unstructured":"Tupone MG, D'Aguanno S, Di Martile M, Valentini E, Desideri M, Trisciuoglio D, Donzelli S, Sacconi A, Buglioni S, Ercolani C, Biagioni A, Fibbi G, Fattore L, Mancini R, Ciliberto G, Blandino G, Del Bufalo D (2020) microRNA-378a-5p iS a novel positive regulator of melanoma progression. Oncogenesis 9(2):22. https:\/\/doi.org\/10.1038\/s41389-020-0203-6","journal-title":"Oncogenesis"},{"key":"4_CR71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.biopha.2017.03.064","volume":"90","author":"J Wu","year":"2017","unstructured":"Wu J, Li J, Ren J, Zhang D (2017) MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7. Biomed Pharmacother 90:303\u2013310","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"4_CR72","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.18632\/oncotarget.2452","volume":"5","author":"S-M Liu","year":"2014","unstructured":"Liu S-M, Lu J, Lee H-C, Chung F-H, Ma N (2014) miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2. Oncotarget 5(19):9444","journal-title":"Oncotarget"},{"issue":"2","key":"4_CR73","first-page":"189","volume":"36","author":"X-e Feng","year":"2021","unstructured":"Feng X-e (2021) miR-548b suppresses melanoma cell growth, migration, and invasion by negatively regulating its target gene HMGB1. Cancer Biother Radiopharm 36(2):189\u2013201","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"4_CR74","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41420-022-01221-z","volume":"8","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chen Y, Shi L, Li J, Wan W, Li B, Liu D, Li X, Chen Y, Xiang M (2022) Extracellular vesicles microRNA-592 of melanoma stem cells promotes metastasis through activation of MAPK\/ERK signaling pathway by targeting PTPN7 in non-stemness melanoma cells. Cell Death discov 8(1):428","journal-title":"Cell Death discov"},{"key":"4_CR75","first-page":"1888501","volume":"2021","author":"X Dong","year":"2021","unstructured":"Dong X, Wang Y, Qu Y, Liu J, Feng X, Xu X (2021) MicroRNA-603 promotes progression of cutaneous melanoma by regulating TBX5. Comput Math Methods Med 2021:1888501","journal-title":"Comput Math Methods Med"},{"issue":"2","key":"4_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.12428","volume":"21","author":"Z Wang","year":"2021","unstructured":"Wang Z, Liu Y (2021) MicroRNA-633 enhances melanoma cell proliferation and migration by suppressing KAI1. Oncol Lett 21(2):1\u20131","journal-title":"Oncol Lett"},{"issue":"5","key":"4_CR77","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.18632\/oncotarget.3070","volume":"6","author":"A Bhattacharya","year":"2015","unstructured":"Bhattacharya A, Schmitz U, Raatz Y, Sch\u00f6nherr M, Kottek T, Schauer M, Franz S, Saalbach A, Anderegg U, Wolkenhauer O, Schadendorf D, Simon JC, Magin T, Vera J, Kunz M (2015) miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy. Oncotarget 6(5):2966\u20132980. https:\/\/doi.org\/10.18632\/oncotarget.3070","journal-title":"Oncotarget"},{"key":"4_CR78","first-page":"8722","volume":"25","author":"Z Xia","year":"2019","unstructured":"Xia Z, Yang C, Yang X, Wu S, Feng Z, Qu L, Chen X, Liu L, Ma Y (2019) MiR-652 promotes proliferation and migration of uveal melanoma cells by targeting HOXA9. Med Sci Monit Int Med J Exp Clin Res 25:8722","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"issue":"2","key":"4_CR79","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s13577-020-00473-0","volume":"34","author":"CC Zhao","year":"2021","unstructured":"Zhao CC, Guo H, Wang Y, Li JH (2021) Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma. Hum Cell 34(2):654\u2013666. https:\/\/doi.org\/10.1007\/s13577-020-00473-0","journal-title":"Hum Cell"},{"key":"4_CR80","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.2147\/cmar.S206461","volume":"11","author":"D Peng","year":"2019","unstructured":"Peng D, Dong J, Zhao Y, Peng X, Tang J, Chen X, Wang L, Hu DN, Reinach PS, Qu J, Yan D (2019) miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGF\u03b2R1, GNAQ, WASL, and RAC1. Cancer Manag Res 11:4729\u20134742. https:\/\/doi.org\/10.2147\/cmar.S206461","journal-title":"Cancer Manag Res"},{"key":"4_CR81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biopha.2016.04.052","volume":"82","author":"H-j Qiu","year":"2016","unstructured":"Qiu H-j, Lu X-h, Yang S-s, Weng C-y, Zhang E-k, Chen F-c (2016) MiR-769 promoted cell proliferation in human melanoma by suppressing GSK3B expression. Biomed Pharmacother 82:117\u2013123","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4_CR82","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/10799893.2020.1804280","volume":"41","author":"W Zhang","year":"2021","unstructured":"Zhang W, Mao K, Liu S, Xu Y, Ren J (2021) miR-942-5p promotes the proliferation and invasion of human melanoma cells by targeting DKK3. J Recep Signal Trans 41(2):180\u2013187","journal-title":"J Recep Signal Trans"},{"key":"4_CR83","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2147\/OTT.S234276","volume":"13","author":"Y Yu","year":"2020","unstructured":"Yu Y, Yu F, Sun P (2020) MicroRNA-1246 promotes melanoma progression through targeting FOXA2. Onco Targets Ther 13:1245\u20131253","journal-title":"Onco Targets Ther"},{"issue":"1","key":"4_CR84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40659-022-00397-z","volume":"55","author":"X Li","year":"2022","unstructured":"Li X, Liu D, Chen H, Zeng B, Zhao Q, Zhang Y, Chen Y, Wang J, Xing HR (2022) Melanoma stem cells promote metastasis via exosomal miR-1268a inactivation of autophagy. Biol Res 55(1):29","journal-title":"Biol Res"},{"key":"4_CR85","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.12143","volume":"9","author":"Z He","year":"2021","unstructured":"He Z, Xin Z, Peng Y, Zhao H, Fang X (2021) Construction of competing endogenous RNA interaction network as prognostic markers in metastatic melanoma. PeerJ 9:e12143. https:\/\/doi.org\/10.7717\/peerj.12143","journal-title":"PeerJ"},{"issue":"4","key":"4_CR86","doi-asserted-by":"publisher","first-page":"188754","DOI":"10.1016\/j.bbcan.2022.188754","volume":"1877","author":"J Pastwi\u0144ska","year":"2022","unstructured":"Pastwi\u0144ska J, Kara\u015b K, Karwaciak I, Ratajewski M (2022) Targeting EGFR in melanoma\u2014the sea of possibilities to overcome drug resistance. Biochim Biophys Acta- Rev Cancer 1877(4):188754. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188754","journal-title":"Biochim Biophys Acta- Rev Cancer"},{"issue":"1","key":"4_CR87","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12015-022-10358-4","volume":"19","author":"D Liu","year":"2023","unstructured":"Liu D, Li X, Zeng B, Zhao Q, Chen H, Zhang Y, Chen Y, Wang J, Xing HR (2023) Exosomal microRNA-4535 of melanoma stem cells promotes metastasis by inhibiting autophagy pathway. Stem Cell Rev Rep 19(1):155\u2013169","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"4_CR88","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/cancers15010080","volume":"15","author":"Q Ye","year":"2023","unstructured":"Ye Q, Li Z, Li Y, Li Y, Zhang Y, Gui R, Cui Y, Zhang Q, Qian L, Xiong Y, Yu Y (2023) Exosome-derived microRNA: implications in melanoma progression, diagnosis and treatment. Cancers 15(1):80","journal-title":"Cancers"},{"issue":"11","key":"4_CR89","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.3390\/ijms24119160","volume":"24","author":"E Antonova","year":"2023","unstructured":"Antonova E, Hambikova A, Shcherbakov D, Sukhov V, Vysochanskaya S, Fadeeva I, Gorshenin D, Sidorova E, Kashutina M, Zhdanova A, Mitrokhin O, Avvakumova N, Zhernov Y (2023) Determination of common microRNA biomarker candidates in stage IV melanoma patients and a human melanoma cell line: a potential anti-melanoma agent screening model. Int J Mol Sci 24(11):9160","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4_CR90","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.3390\/ijms24065386","volume":"24","author":"A Poniewierska-Baran","year":"2023","unstructured":"Poniewierska-Baran A, Zadroga \u0141, Danilyan E, Ma\u0142kowska P, Nied\u017awiedzka-Rystwej P, Pawlik A (2023) MicroRNA as a diagnostic tool, therapeutic target and potential biomarker in cutaneous malignant melanoma detection\u2014narrative review. Int J Mol Sci 24(6):5386","journal-title":"Int J Mol Sci"},{"key":"4_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154424","volume":"244","author":"GM Abd-Allah","year":"2023","unstructured":"Abd-Allah GM, Ismail A, El-Mahdy HA, Elsakka EGE, El-Husseiny AA, Abdelmaksoud NM, Salman A, Elkhawaga SY, Doghish AS (2023) miRNAs as potential game-changers in melanoma: a comprehensive review. Pathol Res Pract 244:154424. https:\/\/doi.org\/10.1016\/j.prp.2023.154424","journal-title":"Pathol Res Pract"},{"key":"4_CR92","doi-asserted-by":"publisher","unstructured":"Ghafouri-Fard S, Gholipour M, Taheri M (2021) MicroRNA signature in melanoma: biomarkers and therapeutic targets. Front Oncol 11. https:\/\/doi.org\/10.3389\/fonc.2021.608987","DOI":"10.3389\/fonc.2021.608987"},{"issue":"1","key":"4_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/14737159.2020.1696194","volume":"20","author":"S Carpi","year":"2020","unstructured":"Carpi S, Polini B, Fogli S, Podest\u00e0 A, Yl\u00f6sm\u00e4ki E, Cerullo V, Romanini A, Nieri P (2020) Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma. Expert Rev Mol Diagn 20(1):19\u201330. https:\/\/doi.org\/10.1080\/14737159.2020.1696194","journal-title":"Expert Rev Mol Diagn"},{"issue":"12","key":"4_CR94","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1172\/JCI98060","volume":"128","author":"V Huber","year":"2018","unstructured":"Huber V, Vallacchi V, Fleming V, Hu X, Cova A, Dugo M, Shahaj E, Sulsenti R, Vergani E, Filipazzi P, De Laurentiis A, Lalli L, Di Guardo L, Patuzzo R, Vergani B, Casiraghi E, Cossa M, Gualeni A, Bollati V, Arienti F, De Braud F, Mariani L, Villa A, Altevogt P, Umansky V, Rodolfo M, Rivoltini L (2018) Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma. J Clin Invest 128(12):5505\u20135516. https:\/\/doi.org\/10.1172\/JCI98060","journal-title":"J Clin Invest"},{"key":"4_CR95","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7831","volume":"7","author":"T Lu","year":"2019","unstructured":"Lu T, Chen S, Qu L, Wang Y, Chen HD, He C (2019) Identification of a five-miRNA signature predicting survival in cutaneous melanoma cancer patients. PeerJ 7:e7831. https:\/\/doi.org\/10.7717\/peerj.7831","journal-title":"PeerJ"},{"issue":"1","key":"4_CR96","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-018-0819-8","volume":"17","author":"M Galasso","year":"2018","unstructured":"Galasso M, Morrison C, Minotti L, Corr\u00e0 F, Zerbinati C, Agnoletto C, Baldassari F, Fassan M, Bartolazzi A, Vecchione A, Nuovo GJ, Di Leva G, D\u2019Atri S, Alvino E, Previati M, Nickoloff BJ, Croce CM, Volinia S (2018) Loss of miR-204 expression is a key event in melanoma. Mol Cancer 17(1):71. https:\/\/doi.org\/10.1186\/s12943-018-0819-8","journal-title":"Mol Cancer"},{"issue":"5","key":"4_CR97","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1089\/cmb.2019.0198","volume":"27","author":"Y Xu","year":"2019","unstructured":"Xu Y, Wang L, Jiang L, Zhang X (2019) Novel MicroRNA biomarkers, miR-142-5p, miR-550a, miR-1826, and miR-1201, were identified for primary melanoma. J Comput Biol 27(5):815\u2013824. https:\/\/doi.org\/10.1089\/cmb.2019.0198","journal-title":"J Comput Biol"},{"key":"4_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112832","volume":"149","author":"Y Tan","year":"2022","unstructured":"Tan Y, Tang F, Li J, Yu H, Wu M, Wu Y, Zeng H, Hou K, Zhang Q (2022) Tumor-derived exosomes: the emerging orchestrators in melanoma. Biomed Pharmacother 149:112832. https:\/\/doi.org\/10.1016\/j.biopha.2022.112832","journal-title":"Biomed Pharmacother"},{"key":"4_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116213","volume":"172","author":"Y Zhan","year":"2024","unstructured":"Zhan Y, Yang Z, Zeng H, Yu J, Chen X, Wu Y (2024) Extracellular vesicle-derived non-coding RNAs in remodeling melanoma. Biomed Pharmacother 172:116213. https:\/\/doi.org\/10.1016\/j.biopha.2024.116213","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4_CR100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/CMR.0000000000000450","volume":"28","author":"L Tengda","year":"2018","unstructured":"Tengda L, Shuping L, Mingli G, Jie G, Yun L, Weiwei Z, Anmei D (2018) Serum exosomal microRNAs as potent circulating biomarkers for melanoma. Melanoma Res 28(4):295","journal-title":"Melanoma Res"},{"issue":"1","key":"4_CR101","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s12935-021-02164-8","volume":"21","author":"Y Guo","year":"2021","unstructured":"Guo Y, Zhang X, Wang L, Li M, Shen M, Zhou Z, Zhu S, Li K, Fang Z, Yan B, Zhao S, Su J, Chen X, Peng C (2021) The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma. Cancer Cell Int 21(1):487. https:\/\/doi.org\/10.1186\/s12935-021-02164-8","journal-title":"Cancer Cell Int"},{"key":"4_CR102","doi-asserted-by":"publisher","unstructured":"Svedman FC, Lohcharoenkal W, Bottai M, Brage SE, Sonkoly E, Hansson J, Pivarcsi A, Eriksson H (2018) Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma. PLoS One 13(11). https:\/\/doi.org\/10.1371\/journal.pone.0206942","DOI":"10.1371\/journal.pone.0206942"},{"issue":"3","key":"4_CR103","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1111\/jdv.16060","volume":"34","author":"B S\u00e1nchez-Sendra","year":"2020","unstructured":"S\u00e1nchez-Sendra B, Garc\u00eda-Gim\u00e9nez JL, Gonz\u00e1lez-Mu\u00f1oz JF, Navarro L, Murgui A, Terr\u00e1dez L, Pinazo I, Martin JM, Monteagudo C (2020) Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging. J Eur Acad Dermatol Venereol 34(3):e126\u2013e129. https:\/\/doi.org\/10.1111\/jdv.16060","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"15","key":"4_CR104","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.3390\/cancers14153706","volume":"14","author":"L Levati","year":"2022","unstructured":"Levati L, Bassi C, Mastroeni S, Lupini L, Antonini Cappellini GC, Bonmassar L, Alvino E, Caporali S, Lacal PM, Narducci MG, Molineris I, De Galitiis F, Negrini M, Russo G, D\u2019Atri S (2022) Circulating miR-1246 and miR-485-3p as promising biomarkers of clinical response and outcome in melanoma patients treated with targeted therapy. Cancers 14(15):3706","journal-title":"Cancers"},{"issue":"7","key":"4_CR105","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41418-018-0205-5","volume":"26","author":"L Fattore","year":"2019","unstructured":"Fattore L, Ruggiero CF, Pisanu ME, Liguoro D, Cerri A, Costantini S, Capone F, Acunzo M, Romano G, Nigita G, Mallardo D, Ragone C, Carriero MV, Budillon A, Botti G, Ascierto PA, Mancini R, Ciliberto G (2019) Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma. Cell Death Differ 26(7):1267\u20131282. https:\/\/doi.org\/10.1038\/s41418-018-0205-5","journal-title":"Cell Death Differ"},{"issue":"1","key":"4_CR106","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/ijms24010716","volume":"24","author":"DL Zob","year":"2023","unstructured":"Zob DL, Augustin I, Caba L, Panzaru M-C, Popa S, Popa AD, Florea L, Gorduza EV (2023) Genomics and Epigenomics in the molecular biology of melanoma\u2014a prerequisite for biomarkers studies. Int J Mol Sci 24(1):716","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4_CR107","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.26355\/eurrev_201905_17815","volume":"23","author":"YW Sun","year":"2019","unstructured":"Sun YW, Li XH, Wang H, Wu J (2019) MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma. Eur Rev Med Pharmacol Sci 23(9):3876\u20133884. https:\/\/doi.org\/10.26355\/eurrev_201905_17815","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"4_CR108","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40659-020-00278-3","volume":"53","author":"G Zhao","year":"2020","unstructured":"Zhao G, Wei Z, Guo Y (2020) MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma. Biol Res 53(1):11. https:\/\/doi.org\/10.1186\/s40659-020-00278-3","journal-title":"Biol Res"},{"key":"4_CR109","doi-asserted-by":"publisher","unstructured":"Xu SJ, Xu WJ, Zeng Z, Zhang M, Zhang DY (2020) MiR-424 functions as potential diagnostic and prognostic biomarker in melanoma. Clin Lab 66(7). https:\/\/doi.org\/10.7754\/Clin.Lab.2019.190917","DOI":"10.7754\/Clin.Lab.2019.190917"},{"issue":"1","key":"4_CR110","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1515\/med-2020-0111","volume":"15","author":"J Xiong","year":"2020","unstructured":"Xiong J, Xue Y, Xia Y, Zhao J, Wang Y (2020) Identification of key microRNAs of plasma extracellular vesicles and their diagnostic and prognostic significance in melanoma. Open Med (Poland) 15(1):464\u2013482. https:\/\/doi.org\/10.1515\/med-2020-0111","journal-title":"Open Med (Poland)"},{"issue":"14","key":"4_CR111","doi-asserted-by":"publisher","first-page":"12110","DOI":"10.18632\/oncotarget.3661","volume":"6","author":"C Margue","year":"2015","unstructured":"Margue C, Reinsbach S, Philippidou D, Beaume N, Walters C, Schneider JG, Nashan D, Behrmann I, Kreis S (2015) Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer? Oncotarget 6(14):12110\u201312127. https:\/\/doi.org\/10.18632\/oncotarget.3661","journal-title":"Oncotarget"},{"issue":"5","key":"4_CR112","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/modpathol.2016.44","volume":"29","author":"S Babapoor","year":"2016","unstructured":"Babapoor S, Horwich M, Wu R, Levinson S, Gandhi M, Makkar H, Kristjansson A, Chang M, Dadras SS (2016) microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis. Mod Pathol 29(5):461\u2013475. https:\/\/doi.org\/10.1038\/modpathol.2016.44","journal-title":"Mod Pathol"},{"issue":"11","key":"4_CR113","doi-asserted-by":"publisher","first-page":"20193","DOI":"10.1002\/jcp.28619","volume":"234","author":"P Sahranavardfard","year":"2019","unstructured":"Sahranavardfard P, Firouzi J, Azimi M, Khosravani P, Heydari R, Emami Razavi A, Dorraj M, Keighobadi F, Ebrahimi M (2019) MicroRNA-203 reinforces stemness properties in melanoma and augments tumorigenesis in vivo. J Cell Physiol 234(11):20193\u201320205. https:\/\/doi.org\/10.1002\/jcp.28619","journal-title":"J Cell Physiol"},{"key":"4_CR114","doi-asserted-by":"publisher","unstructured":"Ma M, Li J, Zhang Z, Sun J, Liu Z, Zeng Z, Ouyang S, Kang W (2022) The role and mechanism of microRNA-1224 in human cancer. Front Oncol 12. https:\/\/doi.org\/10.3389\/fonc.2022.858892","DOI":"10.3389\/fonc.2022.858892"},{"issue":"1","key":"4_CR115","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3892\/etm.2018.7005","volume":"17","author":"Q Wang","year":"2019","unstructured":"Wang Q, Zhang R, Liu D (2019) Long non-coding RNA ZEB1-AS1 indicates poor prognosis and promotes melanoma progression through targeting miR-1224-5p. Exp Ther Med 17(1):857\u2013862. https:\/\/doi.org\/10.3892\/etm.2018.7005","journal-title":"Exp Ther Med"},{"key":"4_CR116","doi-asserted-by":"publisher","unstructured":"Sabato C, Noviello TMR, Covre A, Coral S, Caruso FP, Besharat ZM, Splendiani E, Masuelli L, Battistelli C, Vacca A, Catanzaro G, Po A, Anichini A, Maio M, Ceccarelli M, Di Giacomo AM, Ferretti E (2022) A novel microRNA signature for the detection of melanoma by liquid biopsy. J Transl Med 20(1). https:\/\/doi.org\/10.1186\/s12967-022-03668-1","DOI":"10.1186\/s12967-022-03668-1"},{"issue":"10","key":"4_CR117","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/cbin.11027","volume":"43","author":"M Sun","year":"2019","unstructured":"Sun M, Ma X, Tu C, Wang X, Qu J, Wang S, Xiao S (2019) MicroRNA-378 regulates epithelial-mesenchymal transition and metastasis of melanoma by inhibiting FOXN3 expression through the Wnt\/\u03b2-catenin pathway. Cell Biol Int 43(10):1113\u20131124. https:\/\/doi.org\/10.1002\/cbin.11027","journal-title":"Cell Biol Int"},{"issue":"1","key":"4_CR118","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2340\/00015555-2156","volume":"96","author":"V Armand-Labit","year":"2015","unstructured":"Armand-Labit V, Meyer N, Casanova A, Bonnabau H, Platzer V, Tournier E, Sansas B, Verdun S, Thouvenot B, Hilselberger B, Doncescu A, Lamant L, Lacroix-Triki M, Favre G, Pradines A (2015) Identification of a circulating MicroRNA profile as a biomarker of metastatic cutaneous melanoma. Acta Derm Venereol 96(1):29\u201334. https:\/\/doi.org\/10.2340\/00015555-2156","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"4_CR119","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/cancers11010070","volume":"11","author":"C Sol\u00e9","year":"2019","unstructured":"Sol\u00e9 C, Tramonti D, Schramm M, Goicoechea I, Armesto M, Hernandez LI, Manterola L, Fernandez-Mercado M, Mujika K, Tuneu A, Jaka A, Tellaetxe M, Friedl\u00e4nder MR, Estivill X, Piazza P, Ortiz-Romero PL, Middleton MR, Lawrie CH (2019) The circulating transcriptome as a source of biomarkers for melanoma. Cancers 11(1):70","journal-title":"Cancers"},{"issue":"5","key":"4_CR120","doi-asserted-by":"publisher","first-page":"101042831770164","DOI":"10.1177\/1010428317701646","volume":"39","author":"S Fogli","year":"2017","unstructured":"Fogli S, Polini B, Carpi S, Pardini B, Naccarati A, Dubbini N, Lanza M, Breschi MC, Romanini A, Nieri P (2017) Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma. Tumour Biol 39(5):1010428317701646. https:\/\/doi.org\/10.1177\/1010428317701646","journal-title":"Tumour Biol"},{"issue":"6","key":"4_CR121","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/cancers12061692","volume":"12","author":"MA Bustos","year":"2020","unstructured":"Bustos MA, Tran KD, Rahimzadeh N, Gross R, Lin SY, Shoji Y, Murakami T, Boley CL, Tran LT, Cole H, Kelly DF, O\u2019Day S, Hoon DSB (2020) Integrated assessment of circulating cell-free MicroRNA signatures in plasma of patients with melanoma brain metastasis. Cancers 12(6):1692","journal-title":"Cancers"},{"issue":"17","key":"4_CR122","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.7150\/thno.77761","volume":"12","author":"CF Ruggiero","year":"2022","unstructured":"Ruggiero CF, Fattore L, Terrenato I, Sperati F, Salvati V, Madonna G, Capone M, Valenti F, Di Martino S, Mandoj C, Liguoro D, Castaldo V, Cafaro G, Simeone E, Vanella V, Russillo M, Conti L, Cuda G, Giannarelli D, Ascierto PA, Mancini R, Ciliberto G (2022) Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma. Theranostics 12(17):7420\u20137430. https:\/\/doi.org\/10.7150\/thno.77761","journal-title":"Theranostics"},{"issue":"2","key":"4_CR123","doi-asserted-by":"publisher","first-page":"695","DOI":"10.21873\/anticanres.16208","volume":"43","author":"MS Bagheri","year":"2023","unstructured":"Bagheri MS, Polivka J, Treskova I, Houfkova K, Knizkova T, Woznica V, Fikrle T, Pivovarcikova K, Svaton M, Shetti D, Negi R, Pesta M (2023) Preoperative plasma miRNA levels predict prognosis in early-stage malignant melanoma. Anticancer Res 43(2):695. https:\/\/doi.org\/10.21873\/anticanres.16208","journal-title":"Anticancer Res"},{"issue":"5654","key":"4_CR124","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.1091903","volume":"303","author":"CZ Chen","year":"2004","unstructured":"Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303(5654):83\u201386. https:\/\/doi.org\/10.1126\/science.1091903","journal-title":"Science"},{"issue":"10","key":"4_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001020","volume":"2","author":"H Wu","year":"2007","unstructured":"Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N (2007) miRNA profiling of na\u00efve, effector and memory CD8 T cells. PLoS One 2(10):e1020. https:\/\/doi.org\/10.1371\/journal.pone.0001020","journal-title":"PLoS One"},{"key":"4_CR126","doi-asserted-by":"publisher","first-page":"1320305","DOI":"10.3389\/fimmu.2023.1320305","volume":"14","author":"SJ Xu","year":"2023","unstructured":"Xu SJ, Chen JH, Chang S, Li HL (2023) The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. Front Immunol 14:1320305. https:\/\/doi.org\/10.3389\/fimmu.2023.1320305","journal-title":"Front Immunol"},{"issue":"1","key":"4_CR127","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/imr.13024","volume":"304","author":"TC Borbet","year":"2021","unstructured":"Borbet TC, Hines MJ, Koralov SB (2021) MicroRNA regulation of B cell receptor signaling. Immunol Rev 304(1):111\u2013125. https:\/\/doi.org\/10.1111\/imr.13024","journal-title":"Immunol Rev"},{"key":"4_CR128","doi-asserted-by":"publisher","first-page":"iii50","DOI":"10.1136\/ard.2008.100289","volume":"67 Suppl 3","author":"FJ Sheedy","year":"2008","unstructured":"Sheedy FJ, O'Neill LA (2008) Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 67 Suppl 3:iii50\u2013iii55. https:\/\/doi.org\/10.1136\/ard.2008.100289","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4_CR129","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.7150\/thno.53092","volume":"11","author":"X Lai","year":"2021","unstructured":"Lai X, Dreyer FS, Cantone M, Eberhardt M, Gerer KF, Jaitly T, Uebe S, Lischer C, Ekici A, Wittmann J, Jack HM, Schaft N, Dorrie J, Vera J (2021) Network- and systems-based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapy. Theranostics 11(3):1412\u20131428. https:\/\/doi.org\/10.7150\/thno.53092","journal-title":"Theranostics"},{"key":"4_CR130","doi-asserted-by":"publisher","unstructured":"Kluszczynska K, Czyz M (2023) Extracellular vesicles-based cell-cell communication in melanoma: new perspectives in diagnostics and therapy. Int J Mol Sci 24(2). https:\/\/doi.org\/10.3390\/ijms24020965","DOI":"10.3390\/ijms24020965"},{"issue":"11","key":"4_CR131","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, Brenner AJ, Park K, Lee JL, Kim TY, Shin S, Becerra CR, Falchook G, Stoudemire J, Martin D, Kelnar K, Peltier H, Bonato V, Bader AG, Smith S, Kim S, O'Neill V, Beg MS (2020) Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer 122(11):1630\u20131637. https:\/\/doi.org\/10.1038\/s41416-020-0802-1","journal-title":"Br J Cancer"},{"issue":"1","key":"4_CR132","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1684\/ejd.2011.1210","volume":"21","author":"S Michael","year":"2011","unstructured":"Michael S, Thilo G, Daniel S, Peter A, Markus S, Falk GB (2011) Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi. Eur J Dermatol 21(1):18\u201321. https:\/\/doi.org\/10.1684\/ejd.2011.1210","journal-title":"Eur J Dermatol"},{"issue":"1","key":"4_CR133","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00441-012-1446-0","volume":"350","author":"M Sand","year":"2012","unstructured":"Sand M, Skrygan M, Georgas D, Sand D, Gambichler T, Altmeyer P, Bechara FG (2012) The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi. Cell Tissue Res 350(1):119\u2013126. https:\/\/doi.org\/10.1007\/s00441-012-1446-0","journal-title":"Cell Tissue Res"},{"issue":"4","key":"4_CR134","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41388-022-02547-9","volume":"42","author":"L Fattore","year":"2023","unstructured":"Fattore L, Cafaro G, Di Martile M, Campani V, Sacconi A, Liguoro D, Marra E, Bruschini S, Stoppoloni D, Cirombella R, De Nicola F, Pallocca M, Ruggiero CF, Castaldo V, Catizone A, Del Bufalo D, Viglietto G, Vecchione A, Blandino G, Aurisicchio L, Fanciulli M, Ascierto PA, De Rosa G, Mancini R, Ciliberto G (2023) Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance. Oncogene 42(4):293\u2013307. https:\/\/doi.org\/10.1038\/s41388-022-02547-9","journal-title":"Oncogene"},{"issue":"1","key":"4_CR135","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13046-019-1238-4","volume":"38","author":"S Caporali","year":"2019","unstructured":"Caporali S, Amaro A, Levati L, Alvino E, Lacal PM, Mastroeni S, Ruffini F, Bonmassar L, Antonini Cappellini GC, Felli N, Car\u00e8 A, Pfeffer U, D'Atri S (2019) miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A. J Exp Clin Cancer Res 38(1):272. https:\/\/doi.org\/10.1186\/s13046-019-1238-4","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"4_CR136","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/ijms23031647","volume":"23","author":"E De Tomi","year":"2022","unstructured":"De Tomi E, Campagnari R, Orlandi E, Cardile A, Zanr\u00e8 V, Menegazzi M, Gomez-Lira M, Gotte G (2022) Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 melanoma cells correlates with the downregulation of specific Onco-proteins. Int J Mol Sci 23(3):1647","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4_CR137","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s11010-022-04363-x","volume":"477","author":"Q Xie","year":"2022","unstructured":"Xie Q, Zhang R, Liu D, Yang J, Hu Q, Shan C, Li X (2022) Apigenin inhibits growth of melanoma by suppressing miR-512-3p and promoting the G1 phase of cell cycle involving the p27 Kip1 protein. Mol Cell Biochem 477(5):1569\u20131582. https:\/\/doi.org\/10.1007\/s11010-022-04363-x","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"4_CR138","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20(11):675\u2013691. https:\/\/doi.org\/10.1038\/s41576-019-0158-7","journal-title":"Nat Rev Genet"},{"key":"4_CR139","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2016.12.006","volume":"388","author":"J Chen","year":"2017","unstructured":"Chen J, Li Y, Zheng Q, Bao C, He J, Chen B, Lyu D, Zheng B, Xu Y, Long Z, Zhou Y, Zhu H, Wang Y, He X, Shi Y, Huang S (2017) Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett 388:208\u2013219. https:\/\/doi.org\/10.1016\/j.canlet.2016.12.006","journal-title":"Cancer Lett"},{"issue":"2","key":"4_CR140","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41419-017-0204-3","volume":"9","author":"G Chen","year":"2018","unstructured":"Chen G, Shi Y, Liu M, Sun J (2018) circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma. Cell Death Dis 9(2):175. https:\/\/doi.org\/10.1038\/s41419-017-0204-3","journal-title":"Cell Death Dis"},{"issue":"9","key":"4_CR141","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/0008-5472.Can-16-1883","volume":"77","author":"KY Hsiao","year":"2017","unstructured":"Hsiao KY, Lin YC, Gupta SK, Chang N, Yen L, Sun HS, Tsai SJ (2017) Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res 77(9):2339\u20132350. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-1883","journal-title":"Cancer Res"},{"issue":"14","key":"4_CR142","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/s41388-018-0602-8","volume":"38","author":"Z Yang","year":"2019","unstructured":"Yang Z, Qu CB, Zhang Y, Zhang WF, Wang DD, Gao CC, Ma L, Chen JS, Liu KL, Zheng B, Zhang XH, Zhang ML, Wang XL, Wen JK, Li W (2019) Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene 38(14):2516\u20132532. https:\/\/doi.org\/10.1038\/s41388-018-0602-8","journal-title":"Oncogene"},{"issue":"11","key":"4_CR143","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1158\/0008-5472.Can-17-2808","volume":"78","author":"M Qiu","year":"2018","unstructured":"Qiu M, Xia W, Chen R, Wang S, Xu Y, Ma Z, Xu W, Zhang E, Wang J, Fang T, Hu J, Dong G, Yin R, Wang J, Xu L (2018) The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma. Cancer Res 78(11):2839\u20132851. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-2808","journal-title":"Cancer Res"},{"issue":"1","key":"4_CR144","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-018-0914-x","volume":"17","author":"K Zeng","year":"2018","unstructured":"Zeng K, He B, Yang BB, Xu T, Chen X, Xu M, Liu X, Sun H, Pan Y, Wang S (2018) The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer 17(1):160. https:\/\/doi.org\/10.1186\/s12943-018-0914-x","journal-title":"Mol Cancer"},{"key":"4_CR145","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.canlet.2017.06.027","volume":"403","author":"Z Zhong","year":"2017","unstructured":"Zhong Z, Huang M, Lv M, He Y, Duan C, Zhang L, Chen J (2017) Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA\/VEGFR2 signaling pathway. Cancer Lett 403:305\u2013317. https:\/\/doi.org\/10.1016\/j.canlet.2017.06.027","journal-title":"Cancer Lett"},{"key":"4_CR146","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.biopha.2018.08.152","volume":"108","author":"D Bian","year":"2018","unstructured":"Bian D, Wu Y, Song G (2018) Novel circular RNA, hsa_circ_0025039 promotes cell growth, invasion and glucose metabolism in malignant melanoma via the miR-198\/CDK4 axis. Biomed Pharmacother 108:165\u2013176. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.152","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4_CR147","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2018.05.114","volume":"502","author":"W Luan","year":"2018","unstructured":"Luan W, Shi Y, Zhou Z, Xia Y, Wang J (2018) circRNA_0084043 promote malignant melanoma progression via miR-153-3p\/Snail axis. Biochem Biophys Res Commun 502(1):22\u201329. https:\/\/doi.org\/10.1016\/j.bbrc.2018.05.114","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4_CR148","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10565-024-09851-y","volume":"40","author":"Y Yang","year":"2024","unstructured":"Yang Y, Li J, Wei C, Wang L, Gao Z, Shen K, Li Y, Ren M, Zhu Y, Ding Y, Wei C, Zhang T, Zheng S, Lu N, Gu J (2024) Circular RNA circFCHO2(hsa_circ_0002490) promotes the proliferation of melanoma by directly binding to DND1. Cell Biol Toxicol 40(1):9. https:\/\/doi.org\/10.1007\/s10565-024-09851-y","journal-title":"Cell Biol Toxicol"},{"key":"4_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.638548","volume":"9","author":"K Tang","year":"2021","unstructured":"Tang K, Zhang H, Li Y, Sun Q, Jin H (2021) Circular RNA as a potential biomarker for melanoma: a systematic review. Front Cell Dev Biol 9:638548. https:\/\/doi.org\/10.3389\/fcell.2021.638548","journal-title":"Front Cell Dev Biol"},{"issue":"37","key":"4_CR150","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1038\/s41388-021-01977-1","volume":"40","author":"N Mecozzi","year":"2021","unstructured":"Mecozzi N, Vera O, Karreth FA (2021) Squaring the circle: circRNAs in melanoma. Oncogene 40(37):5559\u20135566. https:\/\/doi.org\/10.1038\/s41388-021-01977-1","journal-title":"Oncogene"},{"issue":"5","key":"4_CR151","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41417-019-0130-x","volume":"27","author":"A Abi","year":"2020","unstructured":"Abi A, Farahani N, Molavi G, Gheibi Hayat SM (2020) Circular RNAs: epigenetic regulators in cancerous and noncancerous skin diseases. Cancer Gene Ther 27(5):280\u2013293. https:\/\/doi.org\/10.1038\/s41417-019-0130-x","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"4_CR152","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12957-020-01832-9","volume":"18","author":"S Tian","year":"2020","unstructured":"Tian S, Han G, Lu L, Meng X (2020) Circ-FOXM1 contributes to cell proliferation, invasion, and glycolysis and represses apoptosis in melanoma by regulating miR-143-3p\/FLOT2 axis. World J Surg Oncol 18(1):56. https:\/\/doi.org\/10.1186\/s12957-020-01832-9","journal-title":"World J Surg Oncol"},{"key":"4_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117323","volume":"243","author":"Z Chen","year":"2020","unstructured":"Chen Z, Chen J, Wa Q, He M, Wang X, Zhou J, Cen Y (2020) Knockdown of circ_0084043 suppresses the development of human melanoma cells through miR-429\/tribbles homolog 2 axis and Wnt\/\u03b2-catenin pathway. Life Sci 243:117323. https:\/\/doi.org\/10.1016\/j.lfs.2020.117323","journal-title":"Life Sci"},{"issue":"1","key":"4_CR154","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1080\/21655979.2021.1953822","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Hou Z, Luo B, Li C, Liu J, Liu J, Tang J, Yao G (2021) Circular RNA circRNA_0082835 promotes progression and lymphatic metastasis of primary melanoma by sponging microRNA miRNA-429. Bioengineered 12(1):4159\u20134173. https:\/\/doi.org\/10.1080\/21655979.2021.1953822","journal-title":"Bioengineered"},{"key":"4_CR155","doi-asserted-by":"publisher","unstructured":"Sarkar D, Oghabian A, Bodiyabadu PK, Joseph WR, Leung EY, Finlay GJ, Baguley BC, Askarian-Amiri ME (2017) Multiple isoforms of ANRIL in melanoma cells: structural complexity suggests variations in processing. Int J Mol Sci 18(7). https:\/\/doi.org\/10.3390\/ijms18071378","DOI":"10.3390\/ijms18071378"},{"issue":"4","key":"4_CR156","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3892\/or.2018.6263","volume":"39","author":"Q Wang","year":"2018","unstructured":"Wang Q, Chen J, Wang A, Sun L, Qian L, Zhou X, Liu Y, Tang S, Chen X, Cheng Y, Cao K, Zhou J (2018) Differentially expressed circRNAs in melanocytes and melanoma cells and their effect on cell proliferation and invasion. Oncol Rep 39(4):1813\u20131824. https:\/\/doi.org\/10.3892\/or.2018.6263","journal-title":"Oncol Rep"},{"issue":"24","key":"4_CR157","doi-asserted-by":"publisher","first-page":"10918","DOI":"10.26355\/eurrev_201912_19795","volume":"23","author":"Y Zou","year":"2019","unstructured":"Zou Y, Wang SS, Wang J, Su HL, Xu JH (2019) CircRNA_0016418 expedites the progression of human skin melanoma via miR-625\/YY1 axis. Eur Rev Med Pharmacol Sci 23(24):10918\u201310930. https:\/\/doi.org\/10.26355\/eurrev_201912_19795","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"4_CR158","first-page":"1791","volume":"13","author":"R Lu","year":"2020","unstructured":"Lu R, Zhang X, Li X, Wan X (2020) Circ_0016418 promotes melanoma development and glutamine catabolism by regulating the miR-605-5p\/GLS axis. Int J Clin Exp Pathol 13(7):1791\u20131801","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"4_CR159","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ccell.2019.12.007","volume":"37","author":"D Hanniford","year":"2020","unstructured":"Hanniford D, Ulloa-Morales A, Karz A, Berzoti-Coelho MG, Moubarak RS, S\u00e1nchez-Sendra B, Kloetgen A, Davalos V, Imig J, Wu P, Vasudevaraja V, Argibay D, Lilja K, Tabaglio T, Monteagudo C, Guccione E, Tsirigos A, Osman I, Aifantis I, Hernando E (2020) Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis. Cancer Cell 37(1):55\u201370.e15. https:\/\/doi.org\/10.1016\/j.ccell.2019.12.007","journal-title":"Cancer Cell"},{"issue":"1","key":"4_CR160","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3892\/ol.2018.8700","volume":"16","author":"L Zhang","year":"2018","unstructured":"Zhang L, Li Y, Liu W, Li H, Zhu Z (2018) Analysis of the complex interaction of CDR1as-miRNA-protein and detection of its novel role in melanoma. Oncol Lett 16(1):1219\u20131225. https:\/\/doi.org\/10.3892\/ol.2018.8700","journal-title":"Oncol Lett"},{"issue":"4","key":"4_CR161","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41419-020-2444-x","volume":"11","author":"P Qian","year":"2020","unstructured":"Qian P, Linbo L, Xiaomei Z, Hui P (2020) Circ_0002770, acting as a competitive endogenous RNA, promotes proliferation and invasion by targeting miR-331-3p in melanoma. Cell Death Dis 11(4):264. https:\/\/doi.org\/10.1038\/s41419-020-2444-x","journal-title":"Cell Death Dis"},{"issue":"1","key":"4_CR162","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12943-020-01191-9","volume":"19","author":"CY Wei","year":"2020","unstructured":"Wei CY, Zhu MX, Lu NH, Liu JQ, Yang YW, Zhang Y, Shi YD, Feng ZH, Li JX, Qi FZ, Gu JY (2020) Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p\/CXCL12 axis in melanoma. Mol Cancer 19(1):84. https:\/\/doi.org\/10.1186\/s12943-020-01191-9","journal-title":"Mol Cancer"},{"issue":"1","key":"4_CR163","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12013-019-00895-0","volume":"78","author":"C Jin","year":"2020","unstructured":"Jin C, Dong D, Yang Z, Xia R, Tao S, Piao M (2020) CircMYC regulates glycolysis and cell proliferation in melanoma. Cell Biochem Biophys 78(1):77\u201388. https:\/\/doi.org\/10.1007\/s12013-019-00895-0","journal-title":"Cell Biochem Biophys"},{"issue":"1\u20132","key":"4_CR164","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11010-020-03875-8","volume":"475","author":"J Lu","year":"2020","unstructured":"Lu J, Li Y (2020) Circ_0079593 facilitates proliferation, metastasis, glucose metabolism and inhibits apoptosis in melanoma by regulating the miR-516b\/GRM3 axis. Mol Cell Biochem 475(1\u20132):227\u2013237. https:\/\/doi.org\/10.1007\/s11010-020-03875-8","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"4_CR165","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jdermsci.2021.01.008","volume":"102","author":"F Zhao","year":"2021","unstructured":"Zhao F, Jia Z, Feng Y, Li Z, Feng J (2021) Circular RNA circ_0079593 enhances malignant melanoma progression by the regulation of the miR-573\/ABHD2 axis. J Dermatol Sci 102(1):7\u201315. https:\/\/doi.org\/10.1016\/j.jdermsci.2021.01.008","journal-title":"J Dermatol Sci"},{"issue":"2","key":"4_CR166","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/0960327120950014","volume":"40","author":"D Yin","year":"2021","unstructured":"Yin D, Wei G, Yang F, Sun X (2021) Circular RNA has circ 0001591 promoted cell proliferation and metastasis of human melanoma via ROCK1\/PI3K\/AKT by targeting miR-431-5p. Hum Exp Toxicol 40(2):310\u2013324. https:\/\/doi.org\/10.1177\/0960327120950014","journal-title":"Hum Exp Toxicol"},{"issue":"7","key":"4_CR167","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41419-020-02799-x","volume":"11","author":"J Chen","year":"2020","unstructured":"Chen J, Zhou X, Yang J, Sun Q, Liu Y, Li N, Zhang Z, Xu H (2020) Circ-GLI1 promotes metastasis in melanoma through interacting with p70S6K2 to activate Hedgehog\/GLI1 and Wnt\/\u03b2-catenin pathways and upregulate Cyr61. Cell Death Dis 11(7):596. https:\/\/doi.org\/10.1038\/s41419-020-02799-x","journal-title":"Cell Death Dis"},{"key":"4_CR168","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.canlet.2019.05.036","volume":"459","author":"L Fang","year":"2019","unstructured":"Fang L, Du WW, Awan FM, Dong J, Yang BB (2019) The circular RNA circ-Ccnb1 dissociates Ccnb1\/Cdk1 complex suppressing cell invasion and tumorigenesis. Cancer Lett 459:216\u2013226. https:\/\/doi.org\/10.1016\/j.canlet.2019.05.036","journal-title":"Cancer Lett"},{"issue":"19\u201320","key":"4_CR169","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1101\/gad.329771.119","volume":"33","author":"F Rambow","year":"2019","unstructured":"Rambow F, Marine JC, Goding CR (2019) Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities. Genes Dev 33(19\u201320):1295\u20131318. https:\/\/doi.org\/10.1101\/gad.329771.119","journal-title":"Genes Dev"},{"issue":"12","key":"4_CR170","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/cam4.4627","volume":"11","author":"J Zhang","year":"2022","unstructured":"Zhang J, Cai Y, Sheng S, Zhao C, Jiang B (2022) circITCH suppresses cell proliferation and metastasis through miR-660\/TFCP2 pathway in melanoma. Cancer Med 11(12):2405\u20132413. https:\/\/doi.org\/10.1002\/cam4.4627","journal-title":"Cancer Med"},{"issue":"4","key":"4_CR171","doi-asserted-by":"publisher","first-page":"373","DOI":"10.14670\/hh-18-412","volume":"37","author":"T Hao","year":"2022","unstructured":"Hao T, Yang Y, He J, Bai J, Zheng Y, Luo Z (2022) Knockdown of circular RNA hsa_circ_0062270 suppresses the progression of melanoma via downregulation of CDC45. Histol Histopathol 37(4):373\u2013383. https:\/\/doi.org\/10.14670\/hh-18-412","journal-title":"Histol Histopathol"},{"issue":"3","key":"4_CR172","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jdermsci.2021.08.005","volume":"103","author":"X Chen","year":"2021","unstructured":"Chen X, Tang Y, Yan J, Li L, Jiang L, Chen Y (2021) Circ_0062270 upregulates EPHA2 to facilitate melanoma progression via sponging miR-331-3p. J Dermatol Sci 103(3):176\u2013182. https:\/\/doi.org\/10.1016\/j.jdermsci.2021.08.005","journal-title":"J Dermatol Sci"},{"issue":"17","key":"4_CR173","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1080\/15384101.2022.2072636","volume":"21","author":"X Lin","year":"2022","unstructured":"Lin X, Zhong L, Wang N, Chu X, Liu B (2022) Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661\/RAB3D. Cell Cycle 21(17):1811\u20131826. https:\/\/doi.org\/10.1080\/15384101.2022.2072636","journal-title":"Cell Cycle"},{"issue":"1","key":"4_CR174","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13046-022-02357-7","volume":"41","author":"Q Shang","year":"2022","unstructured":"Shang Q, Du H, Wu X, Guo Q, Zhang F, Gong Z, Jiao T, Guo J, Kong Y (2022) FMRP ligand circZNF609 destabilizes RAC1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma. J Exp Clin Cancer Res 41(1):170. https:\/\/doi.org\/10.1186\/s13046-022-02357-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"4_CR175","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/bab.2153","volume":"69","author":"K Wu","year":"2022","unstructured":"Wu K, Wei Y, Yu Y, Shan M, Tang Y, Sun Y (2022) Green tea polyphenols inhibit malignant melanoma progression via regulating circ_MITF\/miR-30e-3p\/HDAC2 axis. Biotechnol Appl Biochem 69(2):808\u2013821. https:\/\/doi.org\/10.1002\/bab.2153","journal-title":"Biotechnol Appl Biochem"},{"issue":"4","key":"4_CR176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301356","volume":"19","author":"L Zhang","year":"2024","unstructured":"Zhang L, Zhang L, Zhang C, Shi S, Cao Z, Shao C, Li J, Yang Y, Zhang X, Wang J, Li X (2024) circTADA2A inhibited SLC38A1 expression and suppresses melanoma progression through the prevention of CNBP trans-activation. PLoS One 19(4):e0301356. https:\/\/doi.org\/10.1371\/journal.pone.0301356","journal-title":"PLoS One"},{"issue":"4","key":"4_CR177","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15071","volume":"33","author":"L Sun","year":"2024","unstructured":"Sun L, Bin S, Huang C, Wang Q (2024) CircROR1 upregulates CCNE1 expression to promote melanoma invasion and metastasis by recruiting KAT2A. Exp Dermatol 33(4):e15071. https:\/\/doi.org\/10.1111\/exd.15071","journal-title":"Exp Dermatol"},{"issue":"8","key":"4_CR178","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X, Huang S (2015) Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 25(8):981\u2013984. https:\/\/doi.org\/10.1038\/cr.2015.82","journal-title":"Cell Res"},{"key":"4_CR179","doi-asserted-by":"publisher","unstructured":"Seretis K, Boptsi E, Boptsi A (2024) Extracellular vesicles as novel diagnostic and therapeutic agents for non-melanoma skin cancer: a systematic review. Int J Mol Sci 25(5). https:\/\/doi.org\/10.3390\/ijms25052617","DOI":"10.3390\/ijms25052617"},{"issue":"1","key":"4_CR180","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-023-38232-y","volume":"14","author":"Y Dong","year":"2023","unstructured":"Dong Y, Gao Q, Chen Y, Zhang Z, Du Y, Liu Y, Zhang G, Li S, Wang G, Chen X, Liu H, Han L, Ye Y (2023) Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy. Nat Commun 14(1):2540. https:\/\/doi.org\/10.1038\/s41467-023-38232-y","journal-title":"Nat Commun"},{"key":"4_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100877","volume":"37","author":"JG Zhou","year":"2023","unstructured":"Zhou JG, Liang R, Wang HT, Jin SH, Hu W, Frey B, Fietkau R, Hecht M, Ma H, Gaipl US (2023) Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients - knowledge from two independent international studies. Neoplasia 37:100877. https:\/\/doi.org\/10.1016\/j.neo.2023.100877","journal-title":"Neoplasia"},{"key":"4_CR182","doi-asserted-by":"publisher","unstructured":"Wang S, Xiong Y, Zhang Y, Wang H, Chen M, Li J, Luo P, Luo YH, Hecht M, Frey B, Gaipl U, Li X, Zhao Q, Ma H, Zhou JG (2024) TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy. J Immunother Cancer 12(1). https:\/\/doi.org\/10.1136\/jitc-2023-008040","DOI":"10.1136\/jitc-2023-008040"},{"issue":"1","key":"4_CR183","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13059-021-02263-9","volume":"22","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Nguyen TM, Zhang XO, Wang L, Phan T, Clohessy JG, Pandolfi PP (2021) Optimized RNA-targeting CRISPR\/Cas13d technology outperforms shRNA in identifying functional circRNAs. Genome Biol 22(1):41. https:\/\/doi.org\/10.1186\/s13059-021-02263-9","journal-title":"Genome Biol"},{"issue":"9","key":"4_CR184","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.1007\/s00432-022-04434-y","volume":"149","author":"X Wang","year":"2023","unstructured":"Wang X, Cheng Q (2023) Suppression of exosomal hsa_circ_0001005 eliminates the Vemurafenib resistance of melanoma. J Cancer Res Clin Oncol 149(9):5921\u20135936. https:\/\/doi.org\/10.1007\/s00432-022-04434-y","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Methods in Molecular Biology","Computational Biology of Non-Coding RNA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4290-0_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T20:25:11Z","timestamp":1738873511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4290-0_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"ISBN":["9781071642894","9781071642900"],"references-count":185,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4290-0_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"20 December 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}